Keyword search (4,163 papers available)

"Khan S" Authored Publications:

Title Authors PubMed ID
1 The Smart in Smart Cities: A Framework for Image Classification Using Deep Learning Al-Qudah R; Khamayseh Y; Aldwairi M; Khan S; 35746171
ENCS
2 Is subthreshold depression in adolescence clinically relevant? Noyes BK; Munoz DP; Khalid-Khan S; Brietzke E; Booij L; 35429521
PSYCHOLOGY
3 Biallelic variants in TRAPPC10 cause a microcephalic TRAPPopathy disorder in humans and mice Rawlins LE; Almousa H; Khan S; Collins SC; Milev MP; Leslie J; Saint-Dic D; Khan V; Hincapie AM; Day JO; McGavin L; Rowley C; Harlalka GV; Vancollie VE; Ahmad W; Lelliott CJ; Gul A; Yalcin B; Crosby AH; Sacher M; Baple EL; 35298461
BIOLOGY
4 Maturation of temporal saccade prediction from childhood to adulthood: predictive saccades, reduced pupil size and blink synchronization Calancie OG; Brien DC; Huang J; Coe BC; Booij L; Khalid-Khan S; Munoz DP; 34759032
PSYCHOLOGY
5 Reductions of Anxiety Symptoms, State Anxiety, and Anxious Arousal in Youth Playing the Videogame MindLight Compared to Online Cognitive Behavioral Therapy Tsui TYL; DeFrance K; Khalid-Khan S; Granic I; Hollenstein T; 34403591
PSYCHOLOGY
6 Methodological and clinical challenges associated with biomarkers for psychiatric disease: A scoping review. Kirkpatrick RH; Munoz DP; Khalid-Khan S; Booij L; 33221025
PSYCHOLOGY
7 DNA methylation differences in stress-related genes, functional connectivity and gray matter volume in depressed and healthy adolescents. Chiarella J, Schumann L, Pomares FB, Frodl T, Tozzi L, Nemoda Z, Yu P, Szyf M, Khalid-Khan S, Booij L 32479312
PSYCHOLOGY
8 Are biophenotyes the key to select antinflammatory-responsive individuals with major depression? Brietzke E, Booij L, Wieck A, Soares CN, Roberts N, Khalid-Khan S 31476416
PSYCHOLOGY
9 Eating disorders and substance use in adolescents: How substance users differ from nonsubstance users in an outpatient eating disorders treatment clinic. Kirkpatrick R, Booij L, Vance A, Marshall B, Kanellos-Sutton M, Marchand P, Khalid-Khan S 30638270
PSYCHOLOGY
10 Use of routinely available clinical, nutritional, and functional criteria to classify cachexia in advanced cancer patients. Vigano AAL, Morais JA, Ciutto L, Rosenthall L, di Tomasso J, Khan S, Olders H, Borod M, Kilgour RD 27793524
HKAP
11 Hypertension management research priorities from patients, caregivers, and healthcare providers: A report from the Hypertension Canada Priority Setting Partnership Group. Khan N, Bacon SL, Khan S, Perlmutter S, Gerlinsky C, Dermer M, Johnson L, Alves F, McLean D, Laupacis A, Pui M, Berg A, Flowitt F, Hypertension Canada Priority Setting Partnership Group 28944609
HKAP

 

Title:Eating disorders and substance use in adolescents: How substance users differ from nonsubstance users in an outpatient eating disorders treatment clinic.
Authors:Kirkpatrick RBooij LVance AMarshall BKanellos-Sutton MMarchand PKhalid-Khan S
Link:https://www.ncbi.nlm.nih.gov/pubmed/30638270?dopt=Abstract
Publication:
Keywords:
PMID:30638270 Category:Int J Eat Disord Date Added:2019-06-03
Dept Affiliation: PSYCHOLOGY
1 Division of Child and Youth Psychiatry, Kingston Health Sciences Centre, Hotel Dieu Hospital Site, Kingston, Ontario, Canada.
2 Department of Psychiatry, Queen's University, Kingston, Ontario, Canada.
3 Centre for Neuroscience Studies, Queen's University, Botterell Hall, Kingston, Ontario, Canada.
4 Department of Psychology, Queen's University, Kingston, Ontario, Canada.
5 Department of Psychology, Concordia University, Montréal, Québec, Canada.
6 Sainte-Justine Hospital Research Centre, University of Montréal, Montréal, Québec, Canada.

Description:

Eating disorders and substance use in adolescents: How substance users differ from nonsubstance users in an outpatient eating disorders treatment clinic.

Int J Eat Disord. 2019 02;52(2):175-182

Authors: Kirkpatrick R, Booij L, Vance A, Marshall B, Kanellos-Sutton M, Marchand P, Khalid-Khan S

Abstract

OBJECTIVE: The relationship between eating disorders (EDs) and substance use (SU) has only been briefly described in literature using mainly adult populations. This study examined the prevalence and characteristics of SU among patients of an adolescent ED outpatient treatment program.

METHOD: A retrospective chart analysis was conducted to determine and subsequently compare medical status, psychosocial factors, treatment course and outcome between patients with and without SU.

RESULTS: Over 60% of patients with SU status (n?=?203) reported regularly consuming substances. 33.4% of substance users received a diagnosis involving purging behaviors compared to 5.9% of nonusers. Females composed 96.4% and 81.7% of users and nonusers, respectively. Users reported significantly more self-harm (57.7% of users vs. 38.6% of nonusers) but did not differ significantly in terms of trauma (abuse or victimization; 48.3% of users vs. 44.9% of nonusers). The percentage of ideal body weight significantly improved throughout treatment and did not differ by SU with a mean increase of 5.29% (SD?=?13.6) among nonusers compared to 5.45% (SD?=?7.5) of users. While users and nonusers did not differ before and after treatment in ED severity, users were more likely than nonusers to drop-out of treatment (41.5% of users vs. 25.2% of nonusers).

DISCUSSION: Adolescents with SU benefit from ED outpatient treatment as much as those without SU, however, users are more likely to drop-out. Therefore, treatment should target these adolescents' emotional dysregulation to improve treatment compliance. Further research is necessary to determine the efficacy of such an approach.

PMID: 30638270 [PubMed - in process]





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University